产品中心 抗体 其他一抗

所有图片(1/3)

Phospho-PRAS40 (T246) Recombinant Rabbit mAb (S-977-7)

Proline-rich AKT1 substrate 1,40 kDa proline-rich AKT substrate,AKT1S1

货号: S0B0898

Datasheet COA
  • 价格: ¥600
  • 规格:
  • 数量:
申请试用 斯达特大包装询价 大包装询价

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Phospho-PRAS40 (T246)
  • 分子别名

    Proline-rich AKT1 substrate 1; 40 kDa proline-rich AKT substrate; AKT1S1
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm
  • Accession

    Q96B36
  • 克隆号

    S-977-7
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    ICC, WB
  • 反应种属 ?

    Hu
  • 预测反应种属
    (反应种属缩写表)

    Ms
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
Dot Blot 1:1000
WB 1:1000
ICC 1:500
背景介绍
  • PRAS40, which stands for Proline-rich Akt Substrate of 40 kDa, is a multifunctional protein that plays various roles within the cell, especially in biological processes such as cell growth, apoptosis, oxidative stress, autophagy, and angiogenesis. PRAS40 is a substrate of the protein kinase B (PKB/Akt) and also a binding protein for 14-3-3 proteins. It is expressed in a variety of tissues and has multiple phosphorylation sites, with its activity closely related to its phosphorylation status. PRAS40 is involved in several signaling pathways, including the mammalian target of rapamycin (mTOR) pathway, the protein kinase B (PKB/Akt) pathway, nuclear factor kappa-B (NF-κB), proto-oncogene serine/threonine-protein kinase PIM-1 (PIM1), and pyruvate kinase M2 (PKM2). PRAS40 plays a significant role in a variety of human diseases, including cardiovascular diseases, ischemia-reperfusion injury, neurodegenerative diseases, cancer, diabetes, and other metabolic diseases. Moreover, the nuclear localization of PRAS40 is associated with the Akt/mTORC1 signaling axis and the RPL11-HDM2-p53 nucleolar stress response pathway. The phosphorylation of PRAS40, especially at the Thr246 site, mediated by Akt and mTORC1, may have an important impact on mTORC1 activity.

  • 免疫印迹

    • WB result of Phospho-PRAS40 (T246) Recombinant Rabbit mAb
      Blocking/Diluting buffer and concentration: 5% NFDM/TBST
      Primary antibody: Phospho-PRAS40 (T246) Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: untreated HeLa whole cell lysate 20 µg
      Lane 2: HeLa starve overnight, then treated with 100 nM insulin for 5 minutes whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 27 kDa
      Observed MW: 38 kDa
      This blot was developed with high sensitivity substrate

  • 斑点杂交

    • Dot blot result of Phospho-PRAS40 (T246) Recombinant Rabbit mAb
      Lane1: Phospho-PRAS40 (T246) peptide
      Lane2: PRAS40 unmodified peptide
      Primary antibody: Phospho-PRAS40 (T246) Recombinant Rabbit mAb at 1/1000 dilution
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution

  • 免疫细胞化学

    • ICC analysis of HeLa cells starve overnight, then treated with insulin (100nM) for 10 minutes (top panel) and untreated HeLa cells (below panel). Anti- Phospho-PRAS40 (T246) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    评论(0)